Mutation studies in CD3+, CD19+ and CD34+ cell fractions in myeloproliferative disorders with homozygous JAK2V617F in granulocytes
作者： Terra L. Lasho , Ruben Mesa , D. Gary Gilliland , Ayalew Tefferi
DOI: 10.1111/J.1365-2141.2005.05682.X
关键词:
摘要:
elsevier.com
sci-hub.se 参考文章(7)
Robert Kralovics, Francesco Passamonti, Andreas S. Buser, Soon-Siong Teo, Ralph Tiedt, Jakob R. Passweg, Andre Tichelli, Mario Cazzola, Radek C. Skoda, A Gain-of-Function Mutation of JAK2 in Myeloproliferative Disorders The New England Journal of Medicine. ,vol. 352, pp. 1779- 1790 ,(2005) , 10.1056/NEJMOA051113
David P. Steensma, Gordon W. Dewald, Terra L. Lasho, Heather L. Powell, Rebecca F. McClure, Ross L. Levine, D. Gary Gilliland, Ayalew Tefferi, The JAK2 V617F activating tyrosine kinase mutation is an infrequent event in both "atypical" myeloproliferative disorders and myelodysplastic syndromes. Blood. ,vol. 106, pp. 1207- 1209 ,(2005) , 10.1182/BLOOD-2005-03-1183
Terra L. Reeder, Richard J. Bailey, Gordon W. Dewald, Ayalew Tefferi, Both B and T lymphocytes may be clonally involved in myelofibrosis with myeloid metaplasia Blood. ,vol. 101, pp. 1981- 1983 ,(2003) , 10.1182/BLOOD-2002-07-2341
Ayalew Tefferi, D. Gary Gilliland, JAK2 in myeloproliferative disorders is not just another kinase. Cell Cycle. ,vol. 4, pp. 1053- 1056 ,(2005) , 10.4161/CC.4.8.1872
Chloé James, Valérie Ugo, Jean-Pierre Le Couédic, Judith Staerk, François Delhommeau, Catherine Lacout, Loïc Garçon, Hana Raslova, Roland Berger, Annelise Bennaceur-Griscelli, Jean Luc Villeval, Stefan N. Constantinescu, Nicole Casadevall, William Vainchenker, A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera Nature. ,vol. 434, pp. 1144- 1148 ,(2005) , 10.1038/NATURE03546
E Joanna Baxter, Linda M Scott, Peter J Campbell, Clare East, Nasios Fourouclas, Soheila Swanton, George S Vassiliou, Anthony J Bench, Elaine M Boyd, Natasha Curtin, Mike A Scott, Wendy N Erber, Anthony R Green, Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders The Lancet. ,vol. 365, pp. 1054- 1061 ,(2005) , 10.1016/S0140-6736(05)71142-9
智洋 松山, What's going on 造血器腫瘍 A gain-of-function mutation of JAK2 in myeloproliferative disorders. Kralovics R, Passamonti F, Buser AS, Teo SS, Tiedt R, Passweg JR, Tichelli A, Cazzola M, Skoda RC. N Engl J Med. 2005; 352: 1779-90. PMID:15858187.--慢性骨髄増殖性疾患においてJAK2遺伝子の変異が高頻度にみられることを示した論文 Mebio oncology. ,vol. 2, pp. 116- 118 ,(2005)